A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
Year: 2018
Type: article
Study design: Observational Study
Abstract: A high proportion of patients with acute myeloid leukemia who achieve minimal residual disease negative status ultimately relapse because a fraction of pathological clones remains undetected by standard methods. We designed and validated a high-throughput sequencing method for minimal residual disease assessment of cell clonotypes with mutations of NPM1, IDH1/2 and/or FLT3-single nucleotide variants. For clinical validation, 106 follow-up samples from 63 patients in complete remission were studied by sequencing, evaluating the level of mutations detected at diagnosis. The predictive value of minimal residual disease status by sequencing, multiparameter flow cytometry, or quantitative polymerase chain reaction analysis was determined by survival analysis. The sequencing method achieved a sensitivity of 10−4 for single nucleotide variants and 10−5 for insertions/deletions and could be used in acute myeloid leukemia patients who carry any mutation (86% in our diagnostic data set). Sequencing–determined minimal residual disease positive status was associated with lower disease-free survival (hazard ratio 3.4, P=0.005) and lower overall survival (hazard ratio 4.2, P
Source: Haematologica
Authors: Esther Onecha, Maria Linares, Inmaculada Rapado, Yanira Ruiz-Heredia, Pilar Martinez-Sanchez, Teresa Cedena, Marta Pratcorona, Jaime Perez Oteyza, Pilar Herrera, Eva Barragan, Pau Montesinos, Jose Antonio Garcia Vela, Elena Magro, Eduardo Anguita, Angela Figuera, Rosalia Riaza, Pilar Martinez-Barranco, Beatriz Sanchez-Vega, Josep Nomdedeu, Miguel Gallardo, Joaquin Martinez-Lopez, Rosa Ayala
Institutions: Spanish National Cancer Research Centre, Hospital Universitario 12 De Octubre, Centro de Investigación Biomédica en Red de Cáncer, Universidad Complutense de Madrid, Hospital de Sant Pau, Hospital Universitario HM Sanchinarro, Hospital Universitario Ramón y Cajal, Hospital Universitari i Politècnic La Fe, Hospital Universitario de Getafe, Hospital Universitario Príncipe de Asturias, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Hospital Universitario de La Princesa, Hospital Universitario Severo Ochoa, Hospital Universitario Fundación Alcorcón
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
Awards: Alteraciones moleculares involucradas en los mecanismos de refractariedad y recaída de la Leucemia Mieloide Aguda: Implicaciones terapéuticas., Implicaciones clínicas de la detección de mutaciones recurrentes por secuenciación masiva de paneles en Leucemia Mieloide Aguda, y correlación con la sensibilidad a fármacos antileucemia, G2708544407, G3357915508
OpenAlex ID: W2885961002
